28/08/2021 15:08

Các bài nghiên cứu mới về COVID-19 từ ngày 20/08 đến ngày 27/08/2021

Cục Thông tin KH&CN quốc gia trân trọng kính gửi đến các nhà khoa học những nghiên cứu mới nhất về COVID-19 trên thế giới. Bao gồm những bài viết đã được xuất bản chính thức và các bài viết được chấp nhận đăng trên những cơ sở dữ liệu học thuật chính thống từ ngày 20/08 đến ngày 27/082021. Những nghiên cứu công bố trước thời gian này được tổng hợp tại đường link cuối bài

SCIENCEDIRECT

1. Side effects and antibody titer transition of the BNT162b2 messenger ribonucleic acid coronavirus disease 2019 vaccine in Japan

Respiratory Investigation, 19 June 2021, Volume 59, Issue 5, Pages 635-642

Takehiro Izumo, Naoyuki Kuse, Minoru Inomata

https://www.sciencedirect.com/science/article/pii/S2212534521001118/pdfft?md5=eb9d330435b12127a5fb368ddbe6fc78&pid=1-s2.0-S2212534521001118-main.pdf

2. Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study

Seizure, 6 August 2021, Volume 92, Pages 2-9

Fathi Massoud, Samar Farouk Ahmad, Maher Arabi

https://www.sciencedirect.com/science/article/pii/S1059131121002697/pdfft?md5=4f744985c831758838f9dea8fc51621a&pid=1-s2.0-S1059131121002697-main.pdf

3. COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge

Immunity, 2 July 2021, Volume 54, Issue 8, Pages 1869-1882.e6

Anthony T. DiPiazza, Sarah R. Leist, Tracy J. Ruckwardt

https://www.sciencedirect.com/science/article/pii/S1074761321002624/pdfft?md5=6906c6d0a6c0912005abe885c68e7d0d&pid=1-s2.0-S1074761321002624-main.pdf

4. Simultaneous quantification of spike and nucleocapsid protein in inactivated COVID-19 vaccine bulk by liquid chromatography-tandem mass spectrometry

Journal of Chromatography B, 5 August 2021, Volume 1181, Article 122884

Zhen Long, Chen Wei, Tao Bo

https://www.sciencedirect.com/science/article/pii/S1570023221003652/pdfft?md5=ba1b054e76ddac63a9ed5b8d3179ae70&pid=1-s2.0-S1570023221003652-main.pdf

5. Efficacy of COVID-19 vaccines: From clinical trials to real life

Therapies, 12 May 2021, Volume 76, Issue 4, Pages 277-283

Dominique Deplanque, Odile Launay

https://www.sciencedirect.com/science/article/abs/pii/S004059572100127X

6. Safety and Reactogenicity of the ChAdOx1 (AZD1222) COVID-19 Vaccine in Saudi Arabia

International Journal of Infectious Diseases, 25 July 2021, Volume 110, Pages 359-362

Salma Al Bahrani, Ali Albarrak, Jaffar A. Al-Tawfiq

https://www.sciencedirect.com/science/article/pii/S1201971221006081/pdfft?md5=e86857e21e58c7d2f30c3dcf76729cbc&pid=1-s2.0-S1201971221006081-main.pdf

7. Scrutinizing the SARS-CoV-2 protein information for designing an effective vaccine encompassing both the T-cell and B-cell epitopes

Infection, Genetics and Evolution, 29 November 2020, Volume 87, Article 104648

Neha Jain, Uma Shankar, Amit Kumar

https://www.sciencedirect.com/science/article/abs/pii/S1567134820304792

8. Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models

Vaccine, 1 June 2021, Volume 39, Issue 30, Pages 4108-4116

Ayan Dey, T. M. Chozhavel Rajanathan, Kapil Maithal

https://www.sciencedirect.com/science/article/pii/S0264410X21007064

9. Low Rates of Urologic Side Effects Following Coronavirus Disease Vaccination: An Analysis of the Food and Drug Administration Vaccine Adverse Event Reporting System

Urology, 20 April 2021, Volume 153, Pages 11-13

Hanson Zhao, Colby Souders, Jennifer T. Anger

https://www.sciencedirect.com/science/article/abs/pii/S0090429521003253

10. FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system

Med, 29 June 2021, Volume 2, Issue 8, Pages 979-992.e8

Colin Pawlowski, Patrick Lenehan, Venky Soundararajan

https://www.sciencedirect.com/science/article/pii/S2666634021002385/pdfft?md5=bbeac1f9b6165e489ea2fbf404be9fc1&pid=1-s2.0-S2666634021002385-main.pdf

11. Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses

Cell, 30 June 2021, Volume 184, Issue 17, Pages 4401-4413.e10

Anusha Nathan, Elizabeth J. Rossin, Gaurav D. Gaiha

https://www.sciencedirect.com/science/article/pii/S0092867421007972/pdfft?md5=40abef6c850e56324a8ae955328d43ba&pid=1-s2.0-S0092867421007972-main.pdf

12. Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA COVID-19 vaccines

Med, 1 July 2021, Volume 2, Issue 8, Pages 965-978.e5

Reid McMurry, Patrick Lenehan, Venky Soundararajan

https://www.sciencedirect.com/science/article/pii/S2666634021002373/pdfft?md5=35d8ce10049a997829b26e7a12cad4e6&pid=1-s2.0-S2666634021002373-main.pdf

13. Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients

Cell Reports, 23 July 2021, Volume 36, Issue 6, Article 109504

Cristina Bergamaschi, Evangelos Terpos, George N. Pavlakis

https://www.sciencedirect.com/science/article/pii/S2211124721009323/pdfft?md5=1c0d8176dd91a311cf2ef1e03706ad87&pid=1-s2.0-S2211124721009323-main.pdf

14. Polymeric and lipid nanoparticles for delivery of self-amplifying RNA vaccines

Journal of Controlled Release, 18 August 2021, Volume 338, Pages 201-210

Anna K. Blakney, Paul F. McKay, Robin J. Shattock

https://www.sciencedirect.com/science/article/pii/S0168365921004351/pdfft?md5=c3da395f0fc11d6542df2398e562a85a&pid=1-s2.0-S0168365921004351-main.pdf

15. Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2

iScience, 4 August 2021, Volume 24, Issue 9, Article 102941

Jun-Gyu Park, Fatai S. Oladunni, Muhammad Munir

https://www.sciencedirect.com/science/article/pii/S2589004221009093/pdfft?md5=e43e3c7233c75d15f519dbb70bf07947&pid=1-s2.0-S2589004221009093-main.pdf

16. Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer

Cancer Cell, 18 June 2021, Volume 39, Issue 8, Pages 1091-1098.e2

Alfredo Addeo, Pankil K. Shah, Dimpy P. Shah

https://www.sciencedirect.com/science/article/pii/S1535610821003305/pdfft?md5=13f3ba065c0a67fdc5e2c5dadab4ab3b&pid=1-s2.0-S1535610821003305-main.pdf

17. COVID-19 vaccine induced rhabdomyolysis: Case report with literature review

Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 15 June 2021, Volume 15, Issue 4, Article 102170

Mahmoud Nassar, Howard Chung, Eben Kimball

https://www.sciencedirect.com/science/article/pii/S1871402121001880/pdfft?md5=412427f171e7c0319dbf0e04b9979ba3&pid=1-s2.0-S1871402121001880-main.pdf

18. B cells promote CD8 T cell primary and memory responses to subunit vaccines

Cell Reports, 24 August 2021, Volume 36, Issue 8, Article 109591

Jared Klarquist, Eric W. Cross, Ross M. Kedl

https://www.sciencedirect.com/science/article/pii/S2211124721010251/pdfft?md5=5490722c63cd5e59ddba3ea7f7dbe233&pid=1-s2.0-S2211124721010251-main.pdf

19. Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster model

iScience, 9 January 2021, Volume 24, Issue 2, Article 102054

Sreelekshmy Mohandas, Pragya D. Yadav, Balram Bhargava

https://www.sciencedirect.com/science/article/pii/S2589004221000225/pdfft?md5=3e3f6ad23116a2c54bcb73720012e283&pid=1-s2.0-S2589004221000225-main.pdf

20. An integrated virtual screening of compounds from Carica papaya leaves against multiple protein targets of SARS-Coronavirus-2

Results in Chemistry, January 2021, Volume 3, Article 100113

Pandu Hariyono, Christine Patramurti, Maywan Hariono

https://www.sciencedirect.com/science/article/pii/S2211715621000187/pdfft?md5=972c81347b5a132d2b71911d786d3f7b&pid=1-s2.0-S2211715621000187-main.pdf

21. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

The Lancet, 8 December 2020, Volume 397, Issue 10269, Pages 99-111

Merryn Voysey, Sue Ann Costa Clemens, Andrew J Pollard

https://www.sciencedirect.com/science/article/pii/S0140673620326611/pdfft?md5=d8b70e4ab16c59e4384da7795288cb35&pid=1-s2.0-S0140673620326611-main.pdf

22. Higher severe acute respiratory syndrome coronavirus 2 infection rate in pregnant patients

American Journal of Obstetrics and Gynecology, 16 February 2021, Volume 225, Issue 1, Pages 75.e1-75.e16

Erica M. Lokken, G. Gray Taylor, Kristina M. Adams Waldorf

https://www.sciencedirect.com/science/article/abs/pii/S0002937821000983

23. Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects

Cell Reports, 22 June 2021, Volume 36, Issue 2, Article 109353

Madeleine F. Jennewein, Anna J. MacCamy, Leonidas Stamatatos

https://www.sciencedirect.com/science/article/pii/S2211124721007294/pdfft?md5=16144b029c1485e5c05c76bf146713aa&pid=1-s2.0-S2211124721007294-main.pdf

24. Significance of SARS-CoV-2 specific antibody testing during COVID-19 vaccine allocation

Vaccine, 26 June 2021, Volume 39, Issue 35, Pages 5055-5063

Akane B. Fujimoto, Pinar KeskinocakInci Yildirim

https://www.sciencedirect.com/science/article/pii/S0264410X21008288/pdfft?md5=1cf2ef455a5841cecf45892cb45a7d7b&pid=1-s2.0-S0264410X21008288-main.pdf

25. Stability analysis of SEIR model related to efficiency of vaccines for COVID-19 situation

Heliyon, 15 April 2021, Volume 7, Issue 4, Article e06812

Phitchayapak Wintachai, Kiattisak Prathom

https://www.sciencedirect.com/science/article/pii/S2405844021009154/pdfft?md5=54581ae2df15638193d8575f7a8e1e33&pid=1-s2.0-S2405844021009154-main.pdf

26. Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort Study

Transplantation and Cellular Therapy, 30 June 2021, Volume 27, Issue 9, Pages 788-794

Ron Ram, David Hagin, Ronen Ben-Ami

https://www.sciencedirect.com/science/article/pii/S2666636721010277/pdfft?md5=00ec165624f22af802ccc22a9cfa1105&pid=1-s2.0-S2666636721010277-main.pdf

27. Severe acute respiratory syndrome (SARS) coronavirus-2 infection (COVID-19) in pregnancy - An overview

European Journal of Obstetrics & Gynecology and Reproductive Biology, 15 June 2021, Volume 263, Pages 106-116

Wafaa Ali Belail Hammad, Mariam Al Beloushi, Justin C. Konje

https://www.sciencedirect.com/science/article/pii/S0301211521002724/pdfft?md5=ab6715ab492c90b8d46375d2891e6a4a&pid=1-s2.0-S0301211521002724-main.pdf

28. Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial

The Lancet, 29 January 2021, Volume 397, Issue 10275, Pages 682-694

Peter Richmond, Lara Hatchuel, Ralf Clemens

https://www.sciencedirect.com/science/article/pii/S0140673621002415/pdfft?md5=9ec9c6c5a76307702a9b55b7f9056198&pid=1-s2.0-S0140673621002415-main.pdf

29. HUMORAL RESPONSE TO SARS-CoV-2 AND COVID-19 VACCINES IN PATIENTS WITH MULTIPLE SCLEROSIS TREATED WITH IMMUNE RECONSTITUTION THERAPIES

Multiple Sclerosis and Related Disorders, 15 July 2021, Volume 54, Article 103150

Jelena Drulovic, Jovana Ivanovic, Tatjana Pekmezovic

https://www.sciencedirect.com/science/article/pii/S221103482100417X/pdfft?md5=70ea6339191e4fd87e316f83277ab633&pid=1-s2.0-S221103482100417X-main.pdf

30. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

The Lancet, 19 November 2020, Volume 396, Issue 10267, )Pages 1979-1993

Maheshi N Ramasamy, Angela M Minassian, Andrew J Pollard

https://www.sciencedirect.com/science/article/pii/S0140673620324661/pdfft?md5=66a3663b7a3eb8b5a8a5c948da18004c&pid=1-s2.0-S0140673620324661-main.pdf

31. Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know

Blood, 3 June 2021, Volume 138, Issue 4, Pages 293-298

Gowthami M. Arepally, Thomas L. Ortel

https://www.sciencedirect.com/science/article/pii/S0006497121011472/pdfft?md5=f23b8ec27c0219df5738e576254106ce&pid=1-s2.0-S0006497121011472-main.pdf

WILEY:

1. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study

COVIDSurg Collaborative, GlobalSurg Collaborative

Anaesthesia